Docket Room.
S 5797·Federal·senate

A bill to require the Secretary of Health and Human Services to establish a demonstration project to increase access to biosimilar biological products under the Medicare program.

In CommitteeFiled Nov 19, 2026
Sponsor: Sen. Bennet, Michael F. [D-CO] (D)
Latest Action

Read twice and referred to the Committee on Finance.

Nov 19, 2026

Email me when S 5797 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track S 5797. By continuing you agree to the Terms and Privacy Policy.

Legislative status

  1. Introduced
  2. In Committee
  3. Reported by Committee
  4. Floor Vote Scheduled
  5. Passed One Chamber
  6. Passed Both Chambers
  7. Sent to Executive
  8. Signed into Law

Summary

The bill directs the Secretary of Health and Human Services to create a pilot program aimed at expanding the use of biosimilar biological products for Medicare beneficiaries. It seeks to improve patient access and potentially lower drug costs. The measure is currently referred to the Senate Finance Committee.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about S 5797

3 free questions a day, no account

Sponsors

  • Sen. Bennet, Michael F. [D-CO] (D) · sponsor

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when S 5797 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track S 5797 free

Or ask your AI assistant about S 5797 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice